These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 37511550)

  • 1. Epithelial-to-Mesenchymal Transition Gene Signature in Circulating Melanoma Cells: Biological and Clinical Relevance.
    Rapanotti MC; Cugini E; Campione E; Di Raimondo C; Costanza G; Rossi P; Ferlosio A; Bernardini S; Orlandi A; De Luca A; Bianchi L
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minimal Residual Disease in Melanoma:molecular characterization of in transit cutaneous metastases and Circulating Melanoma Cells recognizes an expression panel potentially related to disease progression.
    Rapanotti MC; Viguria TMS; Spallone G; Terrinoni A; Rossi P; Costanza G; Campione E; Lombardo P; Pathirannehalage CD; Orlandi A; Bernardini S; Bianchi L
    Cancer Treat Res Commun; 2020; 25():100262. PubMed ID: 33338742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stem-Mesenchymal Signature Cell Genes Detected in Heterogeneous Circulating Melanoma Cells Correlate With Disease Stage in Melanoma Patients.
    Rapanotti MC; Campione E; Suarez Viguria TM; Spallone G; Costanza G; Rossi P; Orlandi A; Valenti P; Bernardini S; Bianchi L
    Front Mol Biosci; 2020; 7():92. PubMed ID: 32548126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene expression profiling of single circulating tumor cells in ovarian cancer - Establishment of a multi-marker gene panel.
    Blassl C; Kuhlmann JD; Webers A; Wimberger P; Fehm T; Neubauer H
    Mol Oncol; 2016 Aug; 10(7):1030-42. PubMed ID: 27157930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating melanoma cells in the diagnosis and monitoring of melanoma: an appraisal of clinical potential.
    Mumford BS; Robertson GP
    Mol Diagn Ther; 2014 Apr; 18(2):175-83. PubMed ID: 24297151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monosomy 3 Influences Epithelial-Mesenchymal Transition Gene Expression in Uveal Melanoma Patients; Consequences for Liquid Biopsy.
    Soltysova A; Sedlackova T; Dvorska D; Jasek K; Chokhachi Baradaran P; Horvathova Kajabova V; Demkova L; Buocikova V; Kurucova T; Lyskova D; Furdova A; Minarik G; Babal P; Dankova Z; Smolkova B
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33348918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the expressions pattern of miR-10b, 21, 200c, 373 and 520c to find the correlation between epithelial-to-mesenchymal transition and melanoma stem cell potential in isolated cancer stem cells.
    Fomeshi MR; Ebrahimi M; Mowla SJ; Khosravani P; Firouzi J; Khayatzadeh H
    Cell Mol Biol Lett; 2015 Sep; 20(3):448-65. PubMed ID: 26208390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of downregulated NISCH expression in skin cutaneous melanoma: Modulation of tumor cell invasion, migration, and EMT via PAK1 inhibition.
    Hua HK; Zhu HM; Zhang ZG
    Tissue Cell; 2024 Jun; 88():102399. PubMed ID: 38723330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enrichment of circulating melanoma cells (CMCs) using negative selection from patients with metastatic melanoma.
    Joshi P; Jacobs B; Derakhshan A; Moore LR; Elson P; Triozzi PL; Borden E; Zborowski M
    Oncotarget; 2014 May; 5(9):2450-61. PubMed ID: 24811334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating Tumor Cells With Epithelial-to-mesenchymal Transition Phenotypes Associated With Inferior Outcomes in Primary Breast Cancer.
    Mego M; Karaba M; Minarik G; Benca J; Silvia J; Sedlackova T; Manasova D; Kalavska K; Pindak D; Cristofanilli M; Reuben JM; Mardiak J
    Anticancer Res; 2019 Apr; 39(4):1829-1837. PubMed ID: 30952723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The epithelial-mesenchymal transition (EMT) regulatory factor SLUG (SNAI2) is a downstream target of SPARC and AKT in promoting melanoma cell invasion.
    Fenouille N; Tichet M; Dufies M; Pottier A; Mogha A; Soo JK; Rocchi S; Mallavialle A; Galibert MD; Khammari A; Lacour JP; Ballotti R; Deckert M; Tartare-Deckert S
    PLoS One; 2012; 7(7):e40378. PubMed ID: 22911700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of circulating tumor cell enumeration and tumor marker detection in predicting prognosis and treatment effect in metastatic castration-resistant prostate cancer.
    Chang K; Kong YY; Dai B; Ye DW; Qu YY; Wang Y; Jia ZW; Li GX
    Oncotarget; 2015 Dec; 6(39):41825-36. PubMed ID: 26497689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limited genomic heterogeneity of circulating melanoma cells in advanced stage patients.
    Ruiz C; Li J; Luttgen MS; Kolatkar A; Kendall JT; Flores E; Topp Z; Samlowski WE; McClay E; Bethel K; Ferrone S; Hicks J; Kuhn P
    Phys Biol; 2015 Jan; 12(1):016008. PubMed ID: 25574741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between circulating tumor cells and epithelial to mesenchymal transition in early breast cancer.
    Mego M; Cierna Z; Janega P; Karaba M; Minarik G; Benca J; Sedlácková T; Sieberova G; Gronesova P; Manasova D; Pindak D; Sufliarsky J; Danihel L; Reuben JM; Mardiak J
    BMC Cancer; 2015 Jul; 15():533. PubMed ID: 26194471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating melanoma cells and survival in metastatic melanoma.
    Rao C; Bui T; Connelly M; Doyle G; Karydis I; Middleton MR; Clack G; Malone M; Coumans FA; Terstappen LW
    Int J Oncol; 2011 Mar; 38(3):755-60. PubMed ID: 21206975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epithelial-mesenchymal transition status of circulating tumor cells in breast cancer and its clinical relevance.
    Zhou J; Zhu X; Wu S; Guo J; Zhang K; Xu C; Chen H; Jin Y; Sun Y; Zheng S; Chen Y
    Cancer Biol Med; 2020 Feb; 17(1):169-180. PubMed ID: 32296584
    [No Abstract]   [Full Text] [Related]  

  • 17. Detection of circulating melanoma cells in the blood of melanoma patients: a preliminary study.
    Roland CL; Ross MI; Hall CS; Laubacher B; Upshaw J; Anderson AE; Lucci A
    Melanoma Res; 2015 Aug; 25(4):335-41. PubMed ID: 26011119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability of the hybrid epithelial/mesenchymal phenotype.
    Jolly MK; Tripathi SC; Jia D; Mooney SM; Celiktas M; Hanash SM; Mani SA; Pienta KJ; Ben-Jacob E; Levine H
    Oncotarget; 2016 May; 7(19):27067-84. PubMed ID: 27008704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epithelial-mesenchymal transition and stem cell markers in patients with HER2-positive metastatic breast cancer.
    Giordano A; Gao H; Anfossi S; Cohen E; Mego M; Lee BN; Tin S; De Laurentiis M; Parker CA; Alvarez RH; Valero V; Ueno NT; De Placido S; Mani SA; Esteva FJ; Cristofanilli M; Reuben JM
    Mol Cancer Ther; 2012 Nov; 11(11):2526-34. PubMed ID: 22973057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition.
    Gorges TM; Tinhofer I; Drosch M; Röse L; Zollner TM; Krahn T; von Ahsen O
    BMC Cancer; 2012 May; 12():178. PubMed ID: 22591372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.